ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation

The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to: * Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.

NCT Number	NCT06838611
Lead Sponsor	Medical University of Warsaw Collaborators: Poznan University of Medical Sciences, Medical University of Gdansk, National Institute of Cardiology, Warsaw, Poland, Medical University of Silesia, Jagiellonian University
Conditions	Tricuspid Regurgitation, Heart Failure, Valve Heart Disease
Enrollment	300 participants
Start Date	2023-11-14
Primary Completion	2027-11-14 (estimated)
Study Completion	2028-07-01 (estimated)
Updated on ClinicalTrials.gov	2025-02-20